Search results
Results from the WOW.Com Content Network
Cefixime, sold under the brand name Suprax among others, is an antibiotic medication used to treat a number of bacterial infections. [5] These infections include otitis media , strep throat , pneumonia , urinary tract infections , gonorrhea , and Lyme disease . [ 5 ]
It is possible that the Roman emperor Augustus Caesar had either a liver abscess or typhoid fever, and survived by using ice baths and cold compresses as a means of treatment for his fever. [82] There is a statue of the Greek physician, Antonius Musa , [ 90 ] who treated his fever.
Cefditoren. Cefditoren, also known as cefditoren pivoxil is an antibiotic used to treat infections caused by Gram-positive and Gram-negative bacteria that are resistant to other antibiotics. It is mainly used for treatment of community acquired pneumonia. It is taken by mouth and is in the cephalosporin family of antibiotics, which is part of ...
Since August 2012, the third-generation cephalosporin, ceftriaxone, is the only recommended treatment for gonorrhea in the United States (in addition to azithromycin or doxycycline for concurrent Chlamydia treatment). Cefixime is no longer recommended as a first-line treatment due to evidence of decreasing susceptibility. [30] Ceftriaxone ...
Paratyphoid fever. Paratyphoid fever, also known simply as paratyphoid, is a bacterial infection caused by one of three types of Salmonella enterica. [1] Symptoms usually begin 6–30 days after exposure and are the same as those of typhoid fever. [1][3] Often, a gradual onset of a high fever occurs over several days. [1]
Typhoid vaccines are vaccines that prevent typhoid fever. [1][2][3] Several types are widely available: typhoid conjugate vaccine (TCV), Ty21a (a live oral vaccine) and Vi capsular polysaccharide vaccine (ViPS) (an injectable subunit vaccine). They are about 30 to 70% effective in the first two years, depending on the specific vaccine in question.
Ty21a is a live attenuated bacterial vaccine that protects against typhoid.First licensed in Europe in 1983 and in the United States in 1989, it is an orally administered, live-attenuated Ty2 strain of S. Typhi in which multiple genes, including the genes responsible for the production of Vi, have been deleted so as to render it harmless but nevertheless immunogenic.
History of typhoid fever. In 2000, typhoid fever caused an estimated 21.7 million illnesses and 217,000 deaths. [1] It occurs most often in children and young adults between 5 and 19 years old. [2] In 2013, it resulted in about 161,000 deaths – down from 181,000 in 1990. [3] Infants, children, and adolescents in south-central and Southeast ...